PacingCure B.V.
PrivateLast Round
Grant
Nov 22, 2022
Total Funding Raised
$2.91M
Company Overview
PacingCure B.V. operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Grant round in November 2022.
PacingCure B.V. is a biotechnology company that develops precision gene therapies for cardiac arrhythmias and cardiomyopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PacingCure B.V. Comparables
Compare PacingCure B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPace | 80% | |
| Medera | 72% | |
| Renova Therapeutics | 69% |
For institutional investors. Book with your work email.
PacingCure B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 22, 2022 | ||||
| Accelerator | Nov 26, 2020 | ||||
| Convertible Debt | Dec 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PacingCure B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Innovatiefonds Noord-Holland | Convertible Debt |
| Life Sciences @ Work Venture Challenge | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2022
Secured $2.55M from the European Innovation Council Fund.
For institutional investors. Book with your work email.
PacingCure B.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PacingCure B.V.'s valuation, stock price, and market status.
Is PacingCure B.V. a public or private company?
PacingCure B.V. is a private company.
What is the current stock price of PacingCure B.V.?
PacingCure B.V. is a private company, so its shares have no public market price. Caplight tracks PacingCure B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PacingCure B.V. worth (valuation)?
Valuation information for PacingCure B.V. is not publicly available.
Can I buy PacingCure B.V. stock?
PacingCure B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PacingCure B.V.'s last funding round?
PacingCure B.V.'s most recent funding round was Grant on November 22, 2022.
Who are the main investors in PacingCure B.V.?
Key investors in PacingCure B.V. include European Innovation Council Fund, Innovatiefonds Noord-Holland, Life Sciences @ Work Venture Challenge.
Will PacingCure B.V. IPO soon?
No public IPO plans have been announced for PacingCure B.V..
How can I track PacingCure B.V. secondary market activity?
Caplight tracks bids, offers, and trades in PacingCure B.V.'s shares on secondary markets.